Immunology
0 drugs are in development for HIV Infections.
- Companies
- 0
- Clinical trials
- 68
BioSniper AIPage evidence connected
Prepared research question
Which programs lead the HIV Infections pipeline—and what evidence could change the picture?
Run cited research
Traceable citations · Unknowns marked
About this indication
HIV Infections context
Immunology·MeSH: HIV Infections (D015658)
Also known as: HIV Infection, HTLV III Infections, HTLV III LAV Infections, HTLV-III Infection, HTLV-III-LAV Infection, T Lymphotropic Virus Type III Infections, Human
Prevalence
380.0 / 100K
Incidence
12.0 / 100K/yr
Frequently asked questions
How many clinical trials target HIV Infections?
There are 68 clinical trials targeting HIV Infections tracked by BioSniper.
What is the prevalence of HIV Infections?
The estimated prevalence of HIV Infections is approximately 380.0 per 100,000 population.